Pro Share Advisors LLC Myriad Genetics Inc Transaction History

Pro Share Advisors LLC

  • $48.7 Billion
  • Q2 2025

A detailed history of Pro Share Advisors LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 20,341 shares of MYGN stock, worth $158,659. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,341
Previous 21,088 3.54%
Holding current value
$158,659
Previous $187,000 42.25%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
SELL
$3.84 - $8.84 $2,868 - $6,603
-747 Reduced 3.54%
20,341 $108,000
Q1 2025

May 08, 2025
SELL
$8.87 - $14.98 $52,279 - $88,292
-5,894 Reduced 21.84%
21,088 $187,000
Q4 2024

Feb 13, 2025
BUY
$13.17 - $27.03 $38,627 - $79,278
2,933 Added 12.2%
26,982 $369,000
Q3 2024

Nov 13, 2024
BUY
$23.97 - $28.6 $117,668 - $140,397
4,909 Added 25.65%
24,049 $658,000
Q2 2024

Aug 13, 2024
SELL
$17.98 - $25.47 $87,256 - $123,605
-4,853 Reduced 20.23%
19,140 $468,000
Q1 2024

May 08, 2024
BUY
$17.59 - $23.59 $52,594 - $70,534
2,990 Added 14.24%
23,993 $511,000
Q4 2023

Feb 14, 2024
BUY
$13.91 - $21.32 $46,375 - $71,080
3,334 Added 18.87%
21,003 $401,000
Q3 2023

Nov 13, 2023
SELL
$15.99 - $23.22 $3,901 - $5,665
-244 Reduced 1.36%
17,669 $283,000
Q2 2023

Aug 10, 2023
BUY
$17.56 - $23.76 $12,713 - $17,202
724 Added 4.21%
17,913 $415,000
Q1 2023

May 11, 2023
SELL
$15.26 - $23.75 $32,183 - $50,088
-2,109 Reduced 10.93%
17,189 $399,000
Q4 2022

Feb 02, 2023
BUY
$14.51 - $20.99 $22,548 - $32,618
1,554 Added 8.76%
19,298 $280,000
Q3 2022

Nov 04, 2022
BUY
$18.21 - $27.88 $4,552 - $6,970
250 Added 1.43%
17,744 $338,000
Q2 2022

Aug 01, 2022
SELL
$16.45 - $25.88 $139,167 - $218,944
-8,460 Reduced 32.6%
17,494 $318,000
Q1 2022

May 10, 2022
SELL
$22.67 - $28.01 $116,251 - $143,635
-5,128 Reduced 16.5%
25,954 $654,000
Q4 2021

Feb 08, 2022
BUY
$24.13 - $32.63 $59,239 - $80,106
2,455 Added 8.58%
31,082 $857,000
Q3 2021

Nov 12, 2021
SELL
$29.97 - $36.66 $214,974 - $262,962
-7,173 Reduced 20.04%
28,627 $924,000
Q2 2021

Aug 13, 2021
BUY
$25.39 - $32.61 $105,266 - $135,201
4,146 Added 13.1%
35,800 $1.1 Million
Q1 2021

May 14, 2021
BUY
$19.92 - $31.6 $56,453 - $89,554
2,834 Added 9.83%
31,654 $964,000
Q4 2020

Feb 09, 2021
BUY
$12.16 - $19.77 $81,520 - $132,538
6,704 Added 30.31%
28,820 $570,000
Q3 2020

Nov 13, 2020
SELL
$11.25 - $14.75 $21,690 - $28,438
-1,928 Reduced 8.02%
22,116 $288,000
Q2 2020

Aug 03, 2020
BUY
$10.69 - $16.49 $75,674 - $116,732
7,079 Added 41.73%
24,044 $273,000
Q1 2020

May 15, 2020
SELL
$9.78 - $29.53 $123,091 - $371,664
-12,586 Reduced 42.59%
16,965 $243,000
Q4 2019

Feb 12, 2020
SELL
$20.93 - $35.1 $42,697 - $71,604
-2,040 Reduced 6.46%
29,551 $805,000
Q3 2019

Nov 12, 2019
SELL
$22.08 - $47.08 $21,881 - $46,656
-991 Reduced 3.04%
31,591 $904,000
Q2 2019

Aug 13, 2019
SELL
$22.67 - $35.0 $109,745 - $169,435
-4,841 Reduced 12.94%
32,582 $905,000
Q1 2019

May 15, 2019
BUY
$26.93 - $34.7 $10,502 - $13,533
390 Added 1.05%
37,423 $1.24 Million
Q4 2018

Feb 14, 2019
SELL
$27.23 - $45.56 $117,551 - $196,682
-4,317 Reduced 10.44%
37,033 $1.08 Million
Q3 2018

Nov 14, 2018
SELL
$37.57 - $50.34 $22,391 - $30,002
-596 Reduced 1.42%
41,350 $1.9 Million
Q2 2018

Aug 13, 2018
SELL
$27.75 - $40.17 $73,648 - $106,611
-2,654 Reduced 5.95%
41,946 $1.57 Million
Q1 2018

May 14, 2018
SELL
$28.83 - $41.01 $183,618 - $261,192
-6,369 Reduced 12.5%
44,600 $1.32 Million
Q4 2017

Feb 14, 2018
BUY
$28.45 - $37.14 $143,416 - $187,222
5,041 Added 10.98%
50,969 $1.75 Million
Q3 2017

Nov 13, 2017
BUY
$24.01 - $36.2 $68,404 - $103,133
2,849 Added 6.61%
45,928 $1.66 Million
Q2 2017

Aug 11, 2017
BUY
N/A
43,079
43,079 $1.11 Million

Others Institutions Holding MYGN

# of Institutions
234
Shares Held
95.2M
Call Options Held
460K
Put Options Held
14.2K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $629M
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email